Patent details

Basic Information

Publication number:

EP3508579

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP182117614

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PRODUCTION OF RECOMBINANT VACCINE IN E. COLI BY ENZYMATIC CONJUGATION

French Title of Invention:

PRODUCTION D'UN VACCIN RECOMBINANT DANS E. COLI PAR CONJUGAISON ENZYMATIQUE

German Title of Invention:

HERSTELLUNG VON REKOMBINANTEM IMPFSTOFF IN E. COLI DURCH ENZYMATISCHE KONJUGATION

SPC Number:

Dates

Filing date:

07/11/2013

Grant date:

30/06/2021

EP Publication Date:

10/07/2019

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

30/06/2021

EP B1 Publication Date:

30/06/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

07/11/2021

Expiration date:

07/11/2033

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

23/06/2021

 

 

Name:

GlaxoSmithKline Biologicals SA

Address:

Rue de l'Institut, 89, 1330 Rixensart, Belgium (BE)

Inventor

1

Name:

WETTER, Michael

Address:

Switzerland (CH)

2

Name:

WACKER, Michael

Address:

Switzerland (CH)

3

Name:

FARIDMOAYER, Amirreza

Address:

Switzerland (CH)

4

Name:

KOWARIK, Michael

Address:

Switzerland (CH)

Priority

Priority Number:

201261723408 P

Priority Date:

07/11/2012

Priority Country:

United States (US)

Classification

IPC classification:

C12N 15/70; A61K 39/09;

Publication

European Patent Bulletin

Issue number:

202126

Publication date:

30/06/2021

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages